34 分鐘
Tackling the Drug Pricing Reform Fight in a New Congress ELEVATE - a Public Affairs and Communications Podcast by JPA Health
-
- 政治
Almost two-thirds of Americans now give the pharma industry a thumbs up. It’s a stunning reversal from just one year ago when only about one-third (32%) rated the industry positively. What does this mean for drug pricing reform? JPA Health’s Public Affairs team takes on the drug pricing reform debate with a specific focus on health public affairs.
Don’t miss an episode of ELEVATE, subscribe to our podcast on Apple Podcasts, Spotify, and Google Podcasts.
Almost two-thirds of Americans now give the pharma industry a thumbs up. It’s a stunning reversal from just one year ago when only about one-third (32%) rated the industry positively. What does this mean for drug pricing reform? JPA Health’s Public Affairs team takes on the drug pricing reform debate with a specific focus on health public affairs.
Don’t miss an episode of ELEVATE, subscribe to our podcast on Apple Podcasts, Spotify, and Google Podcasts.
34 分鐘